000

SAMSUNG PHARMACEUTICAL

No trades
See on Supercharts

001360 fundamentals

An in-depth look to SAMSUNG PHARMACEUTICAL operating, investing, and financing activities

001360 free cash flow for Q2 24 is -7.54 B KRW. For 2023, 001360 free cash flow was -28.43 B KRW and operating cash flow was -27.66 B KRW.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth